Sanofi, J&J could join GlaxoSmithKline, Reckitt in $20B bidding war for Pfizer OTC: report

26th October 2017 Uncategorised 0

GlaxoSmithKline and Reckitt Benckiser have already declared their interest in Pfizer’s consumer health unit. But they likely won’t be alone when bidding kicks off.

More: Sanofi, J&J could join GlaxoSmithKline, Reckitt in B bidding war for Pfizer OTC: report
Source: fierce